← Open Payments lookup

LINDSAY MUELLER: Open Payments

NPI 1841720653 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,345 in 69 payments from 18 companies in 2025. Trend: 2023 $2,826 · 2024 $2,738 · 2025 $1,345

Food & beverage: $1,345
CompanyPaymentsAmount
ABBVIE INC.20$371
Takeda Pharmaceuticals U.S.A., Inc.12$222
Janssen Biotech, Inc.9$180
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$103
Regeneron Healthcare Solutions, Inc.4$97
Phathom Pharmaceuticals, Inc.4$54
GENZYME CORPORATION1$48
Ipsen Biopharmaceuticals, Inc2$39
Gilead Sciences, Inc.2$34
QOL Medical, LLC2$33

Products named: RINVOQ, TREMFYA, ENTYVIO, DUPIXENT, XIFAXAN, VOQUEZNA, EOHILIA, IQIRVO.

Industry payments across IN — which companies pay providers there.